Optimizing the Use of Tumour Necrosis Factor Inhibitors in Crohn's Disease: A Practical Approach

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.2, 2010-01, pp. : 109-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumour necrosis factor (TNF) inhibitors are an effective option in the management of Crohn's disease

Drugs & Therapy Perspectives, Vol. 26, Iss. 9, 2010-09 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite

The Future Role of Anti-Tumour Necrosis Factor- Products in the Treatment of Crohn's Disease

By van Hogezand R.A. Verspaget H.W.

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 299-305

Adis International

Access to resources Recommend Favorite

Leukaemic Transformation in Patients with Haematological Disease Receiving Tumour Necrosis Factor Inhibitors

By Ferrer-Marín Francisca > Vicente Vicente

Clinical Drug Investigation, Vol. 32, Iss. 6, 2012-06 ,pp. : 423-426

Adis International

Access to resources Recommend Favorite

Immunosuppressants/tumour necrosis factor inhibitors: Legionnaires' disease: 24 case reports

Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Substituted indazole derivatives and their use as inhibitors of PDE4 and the production of tumour necrosis factor

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 1053-1056

Informa Healthcare

Access to resources Recommend Favorite